BeStock  
Markets › Compare › SYRE vs HALO

SYRE vs HALO

Side-by-side comparison of price performance, valuation, growth, profitability, analyst targets and technical trend.

vsvs
SYRE · Spyre Therapeutics$93.47 ▼ 4.26%
HALO · Halozyme Therapeutics$91.35 ▼ 1.82%

One year, rebased to 100

Each line starts at 100 so growth is directly comparable

64154244334423Nov 24, '25May 26, '26Nov 20, '26
  • SYRE +246.6%
  • HALO +23.4%

Head to head

MetricSYREHALO
Price$93.47$91.35
Change today▼ 4.26%▼ 1.82%
Market cap$8.88B$10.41B
Return, 3 months-12.4%-15.9%
Return, year to date+185.3%+35.7%
Return, 1 year+285.3%+29.9%
P/E (TTM)–22.8
P/B9.8-188.4
P/E percentile vs own 5y8th65th
Dividend yield––
Revenue growth (YoY, latest qtr)–+39.2%
Net profit growth (YoY)-759.5%+41.0%
Gross margin–82.3%
Operating margin–55.9%
Net margin–26.9%
Return on equity-42.0%216.4%
Analyst target vs. price+32.0%+37.5%
Analyst buy share100%80%
RSI (14)4620
30-day volatility65.3%60.1%
Max drawdown, 1 year-27.8%-30.4%
Trend readLeaning bearishLeaning bearish
Analyst consensusBuyBuy

Green cells mark the best value in each row where "better" is clear-cut (lower P/E, higher margin). That is a reading of the numbers, not a recommendation. Financials are in each company's reporting currency.

What the numbers say

  • HALO is the largest of the group by market value.
  • SYRE has returned the most over the past year.
  • HALO has been the calmest stock over the last 30 days.

Go deeper

Scroll to Top